House Bill 2038
116th Congress(2019-2020)
State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019
Introduced
Introduced in House on Apr 2, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2038
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019
This bill authorizes health insurance issuers to jointly negotiate the prices for prescription drugs with the manufacturers of such drugs.
April 2, 2019
Sort by most recent
05/15/2019
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
04/02/2019
Referred to the House Committee on the Judiciary.
04/02/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 7:02:23 PM